EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Comparison of Misoprostol and Evening Primrose Oil on Cervical Preparation Before Gynecological Surgery

Nahid Rahbar, Fatemeh Sharafshahi, Sanaz Ghods, Raheb Ghorbani

The Journal of Clinical Pharmacology · 2023

DOI: 10.1002/jcph.2253 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Pharmacology, 2023. Verfasst von Nahid Rahbar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Abnormal Uterine Bleeding Research Center, Semnan University of Medical Sciences, Semnan, Iran. Hauptthemen laut MEDLINE: Misoprostol, Oxytocics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the efficacy and safety of evening primrose oil (EPO) for cervical ripening before gynecologic procedures and compare it to misoprostol. In this study, 40 hysteroscopy and dilation and curettage candidates were enrolled. Patients were randomly assigned to receive either 2000 mg of vaginal EPO ( n = 20) or 200 μg of vaginal misoprostol ( n = 20) 2 hours before the expected procedure. The measured outcomes were the size of the Hegar dilator that passed through the cervix effortlessly, uterine cervicovaginal complications, and drug‐related side effects. The two groups were not significantly different in age, number of gravity, parity, type of delivery, and menopausal status ( P > .05). The mean ± SD size of the first dilator was 5.25 ± 1.55 in the misoprostol group and 7.30 ± 1.08 in the EPO group ( P < .001). The pain complaint in the EPO group was significantly lower ( P = .027), but the two groups were not significantly different in terms of other complications. No cases of uterine or cervical rupture were seen in either group. The present study showed that 2000 mg of vaginal EPO was significantly more effective for cervical ripening than 200 μg of vaginal misoprostol before gynecological surgery. Therefore, it is recommended to use EPO as an alternative to misoprostol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MisoprostolOxytocicsPregnancyHumansFemaleCervix UteriGynecologic Surgical ProceduresAdministration, IntravaginalLinoleic AcidsPlant Oilsgamma-Linolenic AcidOenothera biennis

Stichwörter der Autor:innen

Hegar dilatorcervical ripeningdilation and curettageevening primrosehysteroscopymisoprostol

Substanzen

MisoprostolOxytocicsevening primrose oilLinoleic AcidsPlant Oilsgamma-Linolenic Acid

Autor:innen und Institutionen

  • Abnormal Uterine Bleeding Research Center, Semnan University of Medical Sciences, Semnan, Iran.
  • Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran.

Zitieren

APA

Rahbar, N., Sharafshahi, F., Ghods, S., & Ghorbani, R. (2023). Comparison of Misoprostol and Evening Primrose Oil on Cervical Preparation Before Gynecological Surgery. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2253

Vancouver

Rahbar N, Sharafshahi F, Ghods S, Ghorbani R. Comparison of Misoprostol and Evening Primrose Oil on Cervical Preparation Before Gynecological Surgery. The Journal of Clinical Pharmacology. 2023. doi:10.1002/jcph.2253

BibTeX
@article{Rahbar2023,
  author = {Rahbar, Nahid and Sharafshahi, Fatemeh and Ghods, Sanaz and Ghorbani, Raheb},
  title = {Comparison of Misoprostol and Evening Primrose Oil on Cervical Preparation Before Gynecological Surgery},
  journal = {The Journal of Clinical Pharmacology},
  year = {2023},
  doi = {10.1002/jcph.2253}
}
Kostenlos starten →